qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles

Tumour cellularity, the relative proportion of tumour and normal cells in a sample, affects the sensitivity of mutation detection, copy number analysis, cancer gene expression and methylation profiling. Tumour cellularity is traditionally estimated by pathological review of sectioned specimens; howe...

Full description

Bibliographic Details
Main Authors: Song, Sarah, Nones, Katia, Miller, David, Harliwong, Ivon, Kassahn, Karin S., Pinese, Mark, Pajic, Marina, Gill, Anthony J., Johns, Amber L., Anderson, Matthew, Holmes, Oliver, Leonard, Conrad, Taylor, Darrin, Wood, Scott, Xu, Qinying, Newell, Felicity, Cowley, Mark J., Wu, Jianmin, Wilson, Peter, Fink, Lynn, Biankin, Andrew V., Waddell, Nic, Grimmond, Sean M., Pearson, John V.
Format: Online
Language:English
Published: Public Library of Science 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457972/
id pubmed-3457972
recordtype oai_dc
spelling pubmed-34579722012-10-03 qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles Song, Sarah Nones, Katia Miller, David Harliwong, Ivon Kassahn, Karin S. Pinese, Mark Pajic, Marina Gill, Anthony J. Johns, Amber L. Anderson, Matthew Holmes, Oliver Leonard, Conrad Taylor, Darrin Wood, Scott Xu, Qinying Newell, Felicity Cowley, Mark J. Wu, Jianmin Wilson, Peter Fink, Lynn Biankin, Andrew V. Waddell, Nic Grimmond, Sean M. Pearson, John V. Research Article Tumour cellularity, the relative proportion of tumour and normal cells in a sample, affects the sensitivity of mutation detection, copy number analysis, cancer gene expression and methylation profiling. Tumour cellularity is traditionally estimated by pathological review of sectioned specimens; however this method is both subjective and prone to error due to heterogeneity within lesions and cellularity differences between the sample viewed during pathological review and tissue used for research purposes. In this paper we describe a statistical model to estimate tumour cellularity from SNP array profiles of paired tumour and normal samples using shifts in SNP allele frequency at regions of loss of heterozygosity (LOH) in the tumour. We also provide qpure, a software implementation of the method. Our experiments showed that there is a medium correlation 0.42 (-value = 0.0001) between tumor cellularity estimated by qpure and pathology review. Interestingly there is a high correlation 0.87 (-value 2.2e-16) between cellularity estimates by qpure and deep Ion Torrent sequencing of known somatic KRAS mutations; and a weaker correlation 0.32 (-value = 0.004) between IonTorrent sequencing and pathology review. This suggests that qpure may be a more accurate predictor of tumour cellularity than pathology review. qpure can be downloaded from https://sourceforge.net/projects/qpure/. Public Library of Science 2012-09-25 /pmc/articles/PMC3457972/ /pubmed/23049875 http://dx.doi.org/10.1371/journal.pone.0045835 Text en © 2012 Song et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Song, Sarah
Nones, Katia
Miller, David
Harliwong, Ivon
Kassahn, Karin S.
Pinese, Mark
Pajic, Marina
Gill, Anthony J.
Johns, Amber L.
Anderson, Matthew
Holmes, Oliver
Leonard, Conrad
Taylor, Darrin
Wood, Scott
Xu, Qinying
Newell, Felicity
Cowley, Mark J.
Wu, Jianmin
Wilson, Peter
Fink, Lynn
Biankin, Andrew V.
Waddell, Nic
Grimmond, Sean M.
Pearson, John V.
spellingShingle Song, Sarah
Nones, Katia
Miller, David
Harliwong, Ivon
Kassahn, Karin S.
Pinese, Mark
Pajic, Marina
Gill, Anthony J.
Johns, Amber L.
Anderson, Matthew
Holmes, Oliver
Leonard, Conrad
Taylor, Darrin
Wood, Scott
Xu, Qinying
Newell, Felicity
Cowley, Mark J.
Wu, Jianmin
Wilson, Peter
Fink, Lynn
Biankin, Andrew V.
Waddell, Nic
Grimmond, Sean M.
Pearson, John V.
qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
author_facet Song, Sarah
Nones, Katia
Miller, David
Harliwong, Ivon
Kassahn, Karin S.
Pinese, Mark
Pajic, Marina
Gill, Anthony J.
Johns, Amber L.
Anderson, Matthew
Holmes, Oliver
Leonard, Conrad
Taylor, Darrin
Wood, Scott
Xu, Qinying
Newell, Felicity
Cowley, Mark J.
Wu, Jianmin
Wilson, Peter
Fink, Lynn
Biankin, Andrew V.
Waddell, Nic
Grimmond, Sean M.
Pearson, John V.
author_sort Song, Sarah
title qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
title_short qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
title_full qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
title_fullStr qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
title_full_unstemmed qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
title_sort qpure: a tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles
description Tumour cellularity, the relative proportion of tumour and normal cells in a sample, affects the sensitivity of mutation detection, copy number analysis, cancer gene expression and methylation profiling. Tumour cellularity is traditionally estimated by pathological review of sectioned specimens; however this method is both subjective and prone to error due to heterogeneity within lesions and cellularity differences between the sample viewed during pathological review and tissue used for research purposes. In this paper we describe a statistical model to estimate tumour cellularity from SNP array profiles of paired tumour and normal samples using shifts in SNP allele frequency at regions of loss of heterozygosity (LOH) in the tumour. We also provide qpure, a software implementation of the method. Our experiments showed that there is a medium correlation 0.42 (-value = 0.0001) between tumor cellularity estimated by qpure and pathology review. Interestingly there is a high correlation 0.87 (-value 2.2e-16) between cellularity estimates by qpure and deep Ion Torrent sequencing of known somatic KRAS mutations; and a weaker correlation 0.32 (-value = 0.004) between IonTorrent sequencing and pathology review. This suggests that qpure may be a more accurate predictor of tumour cellularity than pathology review. qpure can be downloaded from https://sourceforge.net/projects/qpure/.
publisher Public Library of Science
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457972/
_version_ 1611911729701191680